Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
You May Also Like
Latest News
A pro-tech advocacy group has released a new report warning of the growing threat posed by China’s artificial intelligence technology and its open-source approach...
Latest News
President-elect Trump dropped his latest round of nominations Saturday afternoon, including two picks to help lead the Department of Justice (DOJ) and one to...
Latest News
Congressional Democrats’ use of X, formerly Twitter, has significantly dropped off in the years since Elon Musk took over the social media platform, a...
Latest News
The Department of Defense (DoD) announced two weapons packages for Ukraine on Monday, totaling $2.47 billion. The first of the two, the Presidential Drawdown...